Cannabis Use and Opioid Prescription Reduction Study

This technical report examines the relationship between cannabis use and the reduction of opioid prescriptions in chronic pain management. The study includes 188 adults aged 34 to 86 diagnosed with chronic pain conditions, analyzing data from cannabis dispensaries and medical records. The findings indicate significant reductions in opioid prescriptions, particularly among patients with cancer pain, who experienced a 71% decrease. Patients with neuropathic pain saw a 19% reduction, while those with musculoskeletal pain had a 3% decrease. The report also details preferences for cannabis products, noting that tablets were the most commonly used form. Additionally, specific THC:CBD ratios were preferred by different patient groups, with a balanced 1:1 ratio being popular among neuropathic pain patients. The results suggest that cannabis may serve as an effective alternative therapy for managing chronic pain and reducing reliance on opioids, although further research is necessary to confirm these findings and explore personalized treatment options.